Login / Signup

Prospective, randomized, double-blind phase 2B trial of the TLPO and TLPLDC vaccines to prevent recurrence of resected stage III/IV melanoma: a prespecified 36-month analysis.

Elizabeth Lee CarpenterSpencer G Van DecarAlexandra M AdamsAnne E O'SheaPatrick M McCarthyRobert Connor ChickGuy Travis CliftonTimothy J VreelandFranklin A ValderaAnkur TiwariDiane HalePhillip Kemp BohanAnnelies HickersonTodd SmolinskyKatryna ThomasJessica CindassJohn HyngstromAdam C BergerJames JakubJeffrey J SussmanMontaser F ShaheenXianzhong YuThomas E WagnerMark FariesGeorge E Peoples
Published in: Journal for immunotherapy of cancer (2023)
NCT02301611.
Keyphrases
  • double blind
  • phase iii
  • placebo controlled
  • phase ii
  • clinical trial
  • open label
  • study protocol
  • lymph node
  • randomized controlled trial